On this page
Ruxolitinib
Active ingredient 2 prescription 5 with labelling
Overview
Source: NDC DirectoryIngredient name
RUXOLITINIB
Base moiety
RUXOLITINIB
RxNorm CUI
UNII
82S8X8XX8H
Medication products
5
Brand names
2
Dosage forms
3
FAERS reports
71,241 · not a risk measure
- RUXOLITINIB Ruxolitinib · Tablet
- RUXOLITINIB Ruxolitinib · Powder
- Ruxolitinib free base Powder
- JAKAFI ruxolitinib · Tablet
- JAKAFI XR ruxolitinib · Tablet, Extended Release
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Tablet | 2 | RUXOLITINIB, JAKAFI |
| Powder | 2 | RUXOLITINIB, Ruxolitinib free base |
| TABLET, Extended Release | 1 | JAKAFI XR |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |